✦ LIBER ✦

Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes

✍ Scribed by Mothaffar F. Rimawi; Priya B. Shetty; Heidi L. Weiss; Rachel Schiff; C. Kent Osborne; Gary C. Chamness; Richard M. Elledge

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 231 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24816

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Heparin-binding epidermal growth factor-

Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome

✍ Christopher Kramer; Kai Klasmeyer; Hans Bojar; Wolfgang A. Schulz; Rolf Ackerman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

## Abstract ## BACKGROUND. Cleavage of membrane‐anchored heparin‐binding epidermal growth factor‐like growth factor (proHB‐EGF) yields a soluble HB‐EGF isoform (sHB‐EGF), which is an activating epidermal growth factor receptor (EGFR) ligand and a C‐terminal fragment HB‐EGF‐C acting directly in the

Expression of epidermal growth factor re

Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas : Association with poor outcome

✍ Kim L. Wang; Tsung-Teh Wu; In Seon Choi; Huamin Wang; Erika Resetkova; Arlene M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

Expression of estrogen, progesterone and

Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer

✍ Ton van Agthoven; Mieke Timmermans; Lambert C. J. Dorssers; Sonja C. Henzen-Logm 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 473 KB 👁 2 views

The prognostic value of epidermal growth factor receptor (EGFR) expression and its biological role in estrogen receptorpositive (ER+) and ER-negative (ER-) primary breast cancer is controversial. In this study, distributions of ER, progesterone receptor and EGFR have been established using immunohis

Co-expression of epidermal growth factor

Co-expression of epidermal growth factor receptor and transforming growth factor-α predicts worse prognosis in breast-cancer patients

✍ Yoshihisa Umekita; Yasuyo Ohi; Yoshiatsu Sagara; Hiroki Yoshida 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 1 views

Expression of growth factors, growth-inh

Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis

✍ de Jong, Johannes S.; van Diest, Paul J.; van der Valk, Paul; Baak, Jan P. A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

Growth factors may play an important role in tumour growth and angiogenesis by their influence on tumour cell proliferation or their effect on neovascularization. The aim of the present study was to determine which of the growth factors, growth-inhibiting factors, and their receptors investigated in

Serum epidermal growth factor receptor/H

Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer

✍ Christopher Souder; Kim Leitzel; Suhail M. Ali; Laurence Demers; Dean B. Evans; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a